Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
10.1002/jcsm.13182 115 ZhangH.QiG.WangK.YangJ.ShenY.YangX.et al (2023b)
Its effects should be considered supportive, not therapeutic, and outcomes may vary between individuals
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy as Well as in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis (NASH) (2023)
mass-based dosing is the only reliable standard across peptide types
US$ 25.66
US$ 25.44
US$ 22.11
US$ 20.39
US$ 20.92
US$ 23.17
